Observation on the efficacy of early restrictive fluid resuscitation in treating severe pneumonia complicated with septic shock
早期限制性液体复苏治疗重症肺炎合并感染性休克的效果观察

摘要

目的 分析早期限制性液体复苏治疗重症肺炎合并感染性休克的效果。方法 2024年6月至2025年6月期间收治重症肺炎合并感染性休克患者，共计60例，以随机分组方式均分为两组，即对照组（常规液体复苏治疗），观察组（早期限制性液体复苏治疗），对实施过程中两组相关指标数据做整理记录，结合统计学系统进行对比观察，分析早期限制性液体复苏治疗应用价值。结果 观察组血流动力学优于对照组，炎症指标低于对照组，临床恢复短于对照组，组间对比P值﹤0.05，可见统计学意义。结论 重症肺炎并发感染性休克早期施行限制性液体复苏疗法，能显著优化患者血流动力学指标，抑制炎症反应，加速患者康复进程，整体疗效显著且可靠，值得在临床中广泛推行。

Abstract

Objective To analyze the efficacy of early restrictive fluid resuscitation in treating severe pneumonia complicated with septic shock.
Methods A total of 60 patients with severe pneumonia complicated with septic shock admitted between June 2024 and June 2025 were randomly divided into two groups: the control group (standard fluid resuscitation therapy) and the observation group (early restrictive fluid resuscitation therapy). Relevant clinical parameters were recorded during treatment, and statistical analysis was performed to compare the therapeutic outcomes.
Results The observation group demonstrated superior hemodynamic parameters compared to the control group, lower inflammatory markers, and shorter clinical recovery time (P-value <0.05, statistically significant).
Conclusion   Early implementation of restrictive fluid resuscitation therapy in severe pneumonia complicated with septic shock can significantly improve hemodynamic indices, suppress inflammatory responses, accelerate disease progression, and achieve reliable clinical outcomes. This approach is worthy of widespread clinical adoption.